摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile | 331950-34-6

中文名称
——
中文别名
——
英文名称
7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile
英文别名
7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile;7-amino-5-(3-chlorophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile;7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-5H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile化学式
CAS
331950-34-6
化学式
C16H13ClN4O3
mdl
——
分子量
344.757
InChiKey
VRCAOQJDGLLMKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    24
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    99.7
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    巴比妥酸3-氯苯甲醛丙二腈 在 zinc oxide-chitosan nanocomposite 作用下, 以 乙醇 为溶剂, 反应 0.22h, 以92%的产率得到7-amino-5-(3-chlorophenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile
    参考文献:
    名称:
    INTRODUCING AN EFFECTIVE NANOCATALYTIC FOR THE ONE-POT SYNTHESIS AND INVESTIGATION OF BIOLOGICAL PROPERTIES OF PYRANOPYRIMIDINONE AND XANTHENE DERIVATIVES
    摘要:
    DOI:
    10.4067/s0717-97072019000404633
点击查看最新优质反应信息

文献信息

  • The first urea-based ionic liquid-stabilized magnetic nanoparticles: an efficient catalyst for the synthesis of bis(indolyl)methanes and pyrano[2,3-<i>d</i>]pyrimidinone derivatives
    作者:Mohammad Ali Zolfigol、Roya Ayazi-Nasrabadi、Saeed Baghery
    DOI:10.1002/aoc.3428
    日期:2016.5
    of bis(indolyl)methane derivatives via the condensation reaction between 2‐methylindole and aldehydes at room temperature under solvent‐free conditions. Also, pyrano[2,3‐d]pyrimidinone derivatives were prepared in the presence of the nanomagnetic urea‐based catalyst by the one‐pot three‐component condensation reaction of 1,3‐dimethylbarbituric acid, aldehydes and malononitrile under solvent‐free conditions
    基于尿素离子液体稳定在二氧化硅包覆的Fe 3 O 4磁性纳米颗粒上,Fe 3 O 4 @SiO 2 @(CH 2)3-尿素-SO 3H / HCl}是碱土中一种无与伦比的,平滑释放的尿素肥料,并通过傅立叶变换红外光谱,可见光和能量分散的X射线光谱,X射线衍射,扫描和透射电子显微镜,原子能对其进行了全面表征。力显微镜和热重分析。纳米结构催化剂是一种新型,绿色,高效的催化剂,它通过2-甲基吲哚与醛在室温下在无溶剂条件下的缩合反应用于合成双(吲哚基)甲烷生物。另外,喃并[2,3- d] pyrimidinone衍生物是在纳米磁性基催化剂存在下,在60°C无溶剂条件下,通过1,3-二甲基巴比妥酸,醛和丙二腈的单锅三组分缩合反应制备的。据我们所知,这是首次合成在二氧化硅包覆的Fe 3 O 4磁性纳米粒子上稳定的离子液体的报告。因此,当前的工作可以在合理设计,合成和应用特定任务的基于肥料
  • Synthesis, characterization and application of ZnFe<sub>2</sub>O<sub>4</sub>nanoparticles as a heterogeneous ditopic catalyst for the synthesis of pyrano[2,3-d] pyrimidines
    作者:Ardeshir Khazaei、Azam Ranjbaran、Fatemeh Abbasi、Marzieh Khazaei、Ahmad Reza Moosavi-Zare
    DOI:10.1039/c4ra16664g
    日期:——

    In the present work, ZnFe2O4nanopowder, as a highly efficient and heterogeneous catalyst, was prepared and fully characterized by IR, UV, XRD, EDX and SEM analysis.

    在目前的工作中,作为一种高效的非均相催化剂,ZnFe2O4纳米粉末通过红外、紫外、X射线衍射、能谱分析和扫描电子显微镜进行了全面表征。
  • Synthesis of pyrano[2,3‐d]pyrimidines and pyrido[2,3‐d]pyrimidines in the magnetized deionized water based on UV–visible study
    作者:Mohammad Bakherad、Ghadamali Bagherian、Amin Rezaeifard、Fatemeh Mosayebi、Behzad Shokoohi、Ali Keivanloo
    DOI:10.1007/s13738-020-02073-z
    日期:2021.4
    Abstract A green synthetic route to the facile one-pot multicomponent synthesis of pyrano[2,3d]pyrimidines and pyrido[2,3d]pyrimidines have been developed using magnetized deionized water (MDW) as a green solvent under catalyst-free conditions. All reactions carried out in a short period of time and the products are obtained in high-to-excellent yields. The developed synthetic technique offers numerous
    摘要 在无催化剂的情况下,使用磁化去离子(MDW)作为绿色溶剂,已经开发出一条绿色的合成路线,可以轻松实现一锅多位合成喃并[2,3- d ]嘧啶吡啶并[2,3- d ]嘧啶。情况。所有反应都在短时间内进行,并且以高至优异的产率获得了产物。与传统的合成方法相比,发达的合成技术具有许多优点,包括环保,清洁合成,简单,成本低,反应时间短,反应产率高以及后处理容易。此外,通过监测普通去离子和MDW中反应混合物的吸收光谱的变化,通过分光光度法跟踪反应速率。 图形摘要
  • 1,8-Diazabicyclo[5.4.0]undec-7-ene: A Highly Efficient Catalyst for One-Pot Synthesis of Substituted Tetrahydro-4<i>H</i>-chromenes, Tetrahydro[<i>b</i>]pyrans, Pyrano[<i>d</i>]pyrimidines, and 4<i>H</i>-Pyrans in Aqueous Medium
    作者:Jitender M. Khurana、Bhaskara Nand、Pooja Saluja
    DOI:10.1002/jhet.1507
    日期:2014.5
    We have reported 1,8‐diazabicyclo[5.4.0]undec‐7‐ene catalyzed one‐pot synthesis of tetrahydro‐4H‐chromenes, tetrahydro[b]pyrans, pyrano[d]pyrimidines and 4H‐pyrans from aldehydes, active methylene compounds malononitrile/ethyl cyanocacetate and activated C–H acids such as dimedone, 1,3‐cyclohexanedione, 1,3‐cyclopentanedione, 1,3‐dimethylbarbituric acid, and ethyl acetoacetate in water under reflux
    我们已经报道了1,8-二氮杂双环[5.4.0]十一碳-7烯从醛催化一锅合成四氢-4 H-苯甲基,四氢[ b ]喃,喃并[ d ]嘧啶和4 H-喃。活性亚甲基化合物丙二腈/乙酸乙酯和活化的C-H酸,如二甲酮1,3-环己二酮,1,3-环戊烷二酮,1,3-二甲基巴比妥酸乙酰乙酸乙酯中回流。该方法的吸引人的特征是温和的反应条件,反应介质的可重​​复使用性,较短的反应时间,易于分离的产物以及优异的产率。版权所有©2013 HeteroCorporation
  • Nano-basic silica as an efficient catalyst for the multi-component preparation of pyrano[2,3-d]pyrimidine derivatives
    作者:Nafisehsadat Sheikhan-Shamsabadi、Majid Ghashang
    DOI:10.1515/mgmc-2016-0034
    日期:2017.1.1
    Abstract A high-yield protocol is explored for the synthesis of pyrano[2,3-d]pyrimidines through the multi-component reaction of aromatic aldehydes, 1,3-Dimethylbarbituric acid, and malononitrile using nano-basic silica as an efficient catalyst. The method tolerates various electron-donating and electron-withdrawing groups on the aromatic ring. Nano-basic silica was characterized by field emission scanning
    摘要 以纳米碱性二氧化硅为有效催化剂,通过芳香醛、1,3-二甲基巴比妥酸丙二腈的多组分反应,探索了一种高产率合成喃并[2,3-d]嘧啶的方案。该方法耐受芳环上的各种给电子和吸电子基团。通过场发射扫描电子显微镜 (FE-SEM) N2 吸附-解吸等温线、动态光散射 (DLS) 和 X 射线粉末衍射 (XRD) 技术对纳米碱性二氧化硅进行了表征。纳米碱性二氧化硅颗粒具有尺寸小于 100 nm 的均匀球体。XRD图显示纳米碱性二氧化硅是无定形的。纳米碱性二氧化硅的比表面积和孔容分布分别为 663 m2g-1 和 0.634 cm3g-1。
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione